Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for sleep quality and anxiety in hemodialysis patients
IRCT20251127068128N2Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of melatonin in sleep disorder and anxiety disorder (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Sleep quality based on Pittsburgh Sleep Quality Index total score and Anxiety level based on GAD-7 score. Started Feb 2026; status: completed.
02
Drugs
melatonin
03
Conditions
sleep disorderanxiety disorder
Beyond the preview
Go deeper on IRCT20251127068128N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251127068128N2.